Prema Abraham

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology · 2008 · 859 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja et al. · Ophthalmology · 2010 · 529 citations

Metabolic Syndrome, Diabetes Management, Diabetes +4

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

David Liao, F Grossi, Delphine El Mehdi et al. · Ophthalmology · 2019 · 491 citations · Full text

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

Prema Abraham, Huibin Yue, Laura Wilson · American Journal of Ophthalmology · 2010 · 443 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +5

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4